Search details
1.
A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung Cancer.
Oncologist
; 28(7): 644-e564, 2023 07 05.
Article
in English
| MEDLINE | ID: mdl-37186063
2.
Case Report of Acute Splenic Sequestration Crisis in an Adult Patient with Hb S Disease and Suspected Hereditary Persistence of Fetal Hemoglobin.
Hemoglobin
; 45(1): 60-61, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-33588663
3.
Trends in surveillance for resected colorectal cancer, 2001-2009.
Cancer
; 121(19): 3525-33, 2015 Oct 01.
Article
in English
| MEDLINE | ID: mdl-26079928
4.
Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer.
Cancer
; 120(1): 77-85, 2014 Jan 01.
Article
in English
| MEDLINE | ID: mdl-24108668
5.
Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression.
Clin Lung Cancer
; 25(1): 50-60.e6, 2024 01.
Article
in English
| MEDLINE | ID: mdl-37813713
6.
Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys
; 119(1): 56-65, 2024 May 01.
Article
in English
| MEDLINE | ID: mdl-37652303
7.
Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab Consolidation.
Clin Lung Cancer
; 25(3): e161-e171, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38195320
8.
Synchronous Primary Lung Cancers Containing Discrete Driver Mutations in a Never-Smoker: Case Report.
Case Rep Oncol
; 16(1): 1384-1389, 2023.
Article
in English
| MEDLINE | ID: mdl-38028577
9.
Brief Report: Second-line treatment outcomes in patients with advanced NSCLC previously treated with first-line immunotherapy regimens.
Clin Lung Cancer
; 24(6): 558-562.e2, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37451933
10.
Utilization and Factors Precluding Receipt of Checkpoint Inhibitor Consolidation for Stage III NSCLC in a Large US Academic Health System.
Clin Lung Cancer
; 24(5): 474-482, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37076396
11.
Clinical Outcomes Associated With Pembrolizumab Monotherapy Among Adults With Diffuse Malignant Peritoneal Mesothelioma.
JAMA Netw Open
; 6(3): e232526, 2023 03 01.
Article
in English
| MEDLINE | ID: mdl-36897589
12.
Platinum Re-Exposure as a Non-Small Cell Lung Cancer (NSCLC) Treatment Strategy in the Age of Immunotherapy.
Clin Lung Cancer
; 23(4): e301-e309, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35093294
13.
Phase II Trial of Combination Nab-paclitaxel and Gemcitabine in Non-squamous Non-small Cell Lung Cancer After Progression on Platinum and Pemetrexed.
Clin Lung Cancer
; 23(4): e310-e316, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35393247
14.
A single-center retrospective cohort study of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma.
PLoS One
; 17(9): e0275187, 2022.
Article
in English
| MEDLINE | ID: mdl-36174024
15.
Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC-Results From a Prospective Pilot Study.
JTO Clin Res Rep
; 3(4): 100301, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35392653
16.
Landscape and Clonal Dominance of Co-occurring Genomic Alterations in Non-Small-Cell Lung Cancer Harboring MET Exon 14 Skipping.
JCO Precis Oncol
; 52021.
Article
in English
| MEDLINE | ID: mdl-34957368
17.
Outcomes in Patients With Non-small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based Therapy.
Clin Lung Cancer
; 22(1): 58-66.e3, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33279417
18.
Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based Therapy.
JCO Precis Oncol
; 52021.
Article
in English
| MEDLINE | ID: mdl-34095713
19.
Management of Lung Cancer During the COVID-19 Pandemic.
JCO Oncol Pract
; 16(9): 579-586, 2020 Sep.
Article
in English
| MEDLINE | ID: mdl-32453656
20.
Early Tumor and Nodal Response in Patients with Locally Advanced Non-Small Cell Lung Carcinoma Predict for Oncologic Outcomes in Patients Treated with Concurrent Proton Therapy and Chemotherapy.
Int J Radiat Oncol Biol Phys
; 106(2): 358-368, 2020 02 01.
Article
in English
| MEDLINE | ID: mdl-31654783